The IWM, MDY, QQQ, and SPY are pausing near major year-over-year levels, suggesting last year's early struggles could recur
Tech stocks have been on fire lately, as evidenced by the Nasdaq Composite's (COMP) run to record highs. In fact, the COMP has been assailing new heights even as the
Dow Jones Industrial Average (DJIA) stalls just shy of 20,000. What's more, the
PowerShares QQQ Trust (QQQ) has just overtaken the
SPDR S&P 500 ETF Trust (
SPY) on a year-over-year basis for the first time since the election, though Schaeffer's Senior V.P. of Research Todd Salamone cautions that both exchange-traded funds (ETFs) could run into a speed bump.
The
iShares Russell 2000 ETF (
IWM) and
SPDR S&P MidCap 400 ETF (MDY) -- based on the Russell 2000 Index (RUT) and S&P MidCap 400 Index (MID), respectively -- are both churning around their 30% year-over-year (YoY) levels, "amid a loss of leadership from the small-cap and mid-cap stocks," Salamone noted in
this week's Monday Morning Outlook. However, you'll note that the IWM and MDY spent an ample amount of time bumping up against their 20% YoY levels before a pullback and subsequent jump. "If the SPY and QQQ behave as IWM and MDY did last year, there is a chance that further advances are capped at 20% YoY," said Salamone.
But note, too, that the YoY anchor point changes daily, resulting in different 20% gain levels. For example, on Feb. 1, SPY's 20% YoY advance will be $232.38, but will drop to $219.43 on Feb. 11. This is due to last year's two-week retreat in SPY, from its Feb. 1 peak to its Feb. 11 trough.
This could be an cautious sign for the aforementioned exchange-traded funds (ETFs), as all four are currently pegged to 2016 anchor points that trended lower through February (albeit by healthy YoY gains). If this trend holds over the next few weeks, it could pressure stocks lower in the near term, mirroring the pattern from early last year.
Schaeffer's Expiration Week Countdown subscribers just made 70.5% GAINS on iShares Russell 2000 ETF (IWM) calls! Sign up now for a trial subscription.